CClinicalTrials.gg
CompletedNCT03265691PRECAHIUpdated Aug 29, 2017

Hyponatremia in the Prevention of Hospitalized Patients Falls

An interventional study of Early detection and treatment of hyponatremia and No Intervention (SOC) in Hyponatremia and Accidental Falls, sponsored by Mª del Carmen Lobo Rodríguez. Completed at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2017-08-29.

Sponsored by Mª del Carmen Lobo Rodríguez · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Cross ecological quasi-experimental study to assess effectiveness of early intervention in the diagnosis and treatment of hyponatremia in the prevention of hospitalized patients´ falls.

Read the detailed description

Effectiveness of early intervention in the diagnosis and treatment of hyponatremia in the prevention of hospitalized patients´ falls.

Aims:

  1. To assess the effectiveness of corrective activity of hyponatremia in falls reducing incidence.
  2. To assess the cost-effectiveness ratio of the two proposed strategies: conventional treatment versus early intervention.

Cross ecological quasi-experimental study. The project will take place in Gregorio Marañón Hospital (Madrid, Spain) in the following inpatient adult Units: Neurology, Rehabilitation 1, Geriatrics, Internal Medicine (Group A), Cardiology, Rehabilitation 2, Gastroenterology, Neurosurgery and Oncology (Group B).

The estimated sample size for a confidence level of 95% (α = 0.05) and power of 90% (β = 0.010), taking into account a decrease in the incidence of falls of 20% restocking losses, is 124 patients per group (ie, the 124 patients receiving regular performance ** and 124 patients receiving the experimental intervention *, if necessary, by participant Unit).

Data collection: In each of the study participants Units both interventions will be held. First the participants Units have been randomized in two groups (Group A: Neurology, Rehabilitation 1, Geriatrics, Internal Medicine; Group B: Cardiology, Rehabilitation 2, Gastroenterology, Neurosurgery and Oncology). All patients hospitalized in these Units will be potentially included. First of all, collaborators will give them an informed consent to ask for their participation.

The interventions are:

  • Experimental intervention: early diagnosis, treatment of hyponatremia until resolution and valuation according to the Dynamic Gait Index test. Duration: 6 months
  • Habitual action: the usual pattern of work will be performed in all patients who enter. Duration: 6 months.
02

Conditions studied

  • Hyponatremia
  • Accidental Falls

Browse trials for

Keywords

  • Accidental Falls
  • Hyponatremia
  • Elderly
  • Risk factors
  • Nurse
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age >65 years
  • Admitted to a participating study unit
  • Wish to participate in the study and signature of informed consent.

Exclusion criteria

Exclusion Criteria:

  • Transfer of the patient to a unit not included in the study
  • Deterioration of the patient's condition to severe or extremely painful
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
124 participants (actual)

Study arms

  • Experimental
    Early hyponatremia diagnosis and treatment

    The early diagnosis of hiponatremia is not a stándar procedure. In the experimental arm, hyponatremia will be diagnosed and treated early.

    Other: Early detection and treatment of hyponatremia · Other: No Intervention (SOC)

  • No intervention
    No intervention

    Usual pattern of work will be performed in all patients who enter in Hospital. Duration: 6 months.

Interventions

  • OtherEarly detection and treatment of hyponatremia

    In the experimental group, hyponatremia will be diagnosed and treated early. Therefore, the researchers will review the patients' sodium levels at admission and throughout their stay.

  • OtherNo Intervention (SOC)

    Usual pattern of work will be performed in all patients who enter in Hospital.

05

What researchers measure

Primary outcomes

  1. To evaluate the effectiveness of treatment of hyponatremia in reducing the incidence of falls.

    The effectiveness will be measured in terms of less incidence of falls

    Time frame: 1 year

Secondary outcomes

  1. To evaluate the cost-effectiveness of the 2 strategies proposed: conventional treatment vs early intervention.

    The cost-effectiveness will be indirectly measured using Average cost per inpatient day

    Time frame: 1 year

06

Study locations

1 site
  • Hospital General Universitario Gregorio Marañón
    Madrid, 28007, Spain
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03265691
Lead sponsor
Mª del Carmen Lobo Rodríguez
Collaborators
Fundación Mutua Madrileña
Responsible party
Mª del Carmen Lobo Rodríguez (Msc Nurse Research, Hospital General Universitario Gregorio Marañon) — Sponsor-investigator
First posted
Aug 29, 2017
Start date
Dec 2014
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Aug 29, 2017

Study contacts

Carmen Lobo-Rodriguez, pHd
principal investigator · carmen.lobo@salud.madrid.org

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion